MapLight Therapeutics
Palo Alto
About MapLight Therapeutics
MapLight Therapeutics offers a platform designed to discover and develop therapeutics for brain disorders. It combines single-cell transcriptomics and optogenetics to identify novel drug targets and develop effective therapies for brain disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Total funding: $640.6M
- Funding stage: IPO
- Last round: Series D (Jul 2025)
- Ticker: nasdaq:MPLT
- Website: maplightrx.com
- Phone: 919-641-8778
Industries & Categories
Biopharma, Biotechnology, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/maplight-therapeutics-51888 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.